硬化症-话题@MedSci

#硬化症#

413篇内容 | 2628人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1982932, encodeId=84dd19829323a, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Clin Nutr：益生菌对多发性硬化症患者的好处实在是太多了！, objectType=article, longId=78141, objectId=badce814131, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=badce814131, replyNumber=0, likeNumber=77, createdTime=2016-10-09, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=badce814131, moduleTitle=Clin Nutr：益生菌对多发性硬化症患者的好处实在是太多了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=badce814131)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982928, encodeId=087f1982928b6, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=诺华新一代免疫调节剂BAF312（siponimod）治疗继发进展型多发性硬化症（SPMS）III期临床获得成功, objectType=article, longId=75977, objectId=1959e5977e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1959e5977e7, replyNumber=0, likeNumber=74, createdTime=2017-04-08, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1959e5977e7, moduleTitle=诺华新一代免疫调节剂BAF312（siponimod）治疗继发进展型多发性硬化症（SPMS）III期临床获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1959e5977e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982918, encodeId=1000198291880, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=喜讯！FDA批准百健/艾伯维每月一次皮下注射多发性硬化症药物Zinbryta, objectType=article, longId=69494, objectId=393e69494f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=393e69494f9, replyNumber=0, likeNumber=0, createdTime=2017-03-29, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=393e69494f9, moduleTitle=喜讯！FDA批准百健/艾伯维每月一次皮下注射多发性硬化症药物Zinbryta, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=393e69494f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982925, encodeId=570d1982925f7, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=【盘点】多发性硬化症（MS）2016年研究新进展, objectType=article, longId=75058, objectId=ab17e5058b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab17e5058b2, replyNumber=0, likeNumber=60, createdTime=2017-01-09, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab17e5058b2, moduleTitle=【盘点】多发性硬化症（MS）2016年研究新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab17e5058b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982926, encodeId=ed621982926ab, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=干细胞疗法真的可以治疗多发性硬化症吗？, objectType=article, longId=75161, objectId=15f3e516178, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15f3e516178, replyNumber=0, likeNumber=73, createdTime=2016-11-23, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15f3e516178, moduleTitle=干细胞疗法真的可以治疗多发性硬化症吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15f3e516178)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982917, encodeId=64a3198291e4f, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Int J Epidemiol：肌萎缩侧索硬化症全球发病率研究（荟萃分析）, objectType=article, longId=69030, objectId=063f6903069, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=063f6903069, replyNumber=0, likeNumber=66, createdTime=2016-08-12, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=063f6903069, moduleTitle=Int J Epidemiol：肌萎缩侧索硬化症全球发病率研究（荟萃分析）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=063f6903069)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982921, encodeId=50ff19829213c, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neuron：在多发性硬化症家系发现核受体基因NR1H3突变, objectType=article, longId=70126, objectId=8921e0126a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8921e0126a5, replyNumber=0, likeNumber=59, createdTime=2016-11-08, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8921e0126a5, moduleTitle=Neuron：在多发性硬化症家系发现核受体基因NR1H3突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8921e0126a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982913, encodeId=cfcd1982913e9, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=AAA 2015：喜大普奔！非处方药或可逆转多发性硬化症所致的视力损伤, objectType=article, longId=66523, objectId=4234665235e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4234665235e, replyNumber=0, likeNumber=80, createdTime=2016-05-17, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4234665235e, moduleTitle=AAA 2015：喜大普奔！非处方药或可逆转多发性硬化症所致的视力损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4234665235e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982923, encodeId=27e11982923c0, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=1年注射2次！罗氏多发性硬化症新药Ocrevus将2017年上市，年销轻松突破20亿美元, objectType=article, longId=71849, objectId=525ae1849d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=525ae1849d6, replyNumber=0, likeNumber=70, createdTime=2016-09-20, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=525ae1849d6, moduleTitle=1年注射2次！罗氏多发性硬化症新药Ocrevus将2017年上市，年销轻松突破20亿美元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=525ae1849d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982908, encodeId=d895198290866, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：大剂量补充维生素D可治疗多发性硬化症, objectType=article, longId=61497, objectId=23706149e8a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23706149e8a, replyNumber=0, likeNumber=73, createdTime=2016-03-20, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23706149e8a, moduleTitle=Neurology：大剂量补充维生素D可治疗多发性硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23706149e8a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982910, encodeId=13231982910c6, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：摄入维生素D或可帮助改善多发性硬化症患者的病情, objectType=article, longId=61827, objectId=00f06182e88, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00f06182e88, replyNumber=0, likeNumber=65, createdTime=2016-11-21, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00f06182e88, moduleTitle=Neurology：摄入维生素D或可帮助改善多发性硬化症患者的病情, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00f06182e88)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982924, encodeId=50ae198292459, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=喜讯！百健和艾伯维每月一次皮下注射多发性硬化症药物Zinbryta获欧盟批准, objectType=article, longId=72275, objectId=7697e227519, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7697e227519, replyNumber=0, likeNumber=94, createdTime=2017-05-09, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7697e227519, moduleTitle=喜讯！百健和艾伯维每月一次皮下注射多发性硬化症药物Zinbryta获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7697e227519)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982905, encodeId=63a31982905fe, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=NEJM：治疗复发性多发性硬化症，达珠单抗HYP优于干扰素β-1α, objectType=article, longId=56988, objectId=34c7569889d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34c7569889d, replyNumber=0, likeNumber=70, createdTime=2016-09-03, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34c7569889d, moduleTitle=NEJM：治疗复发性多发性硬化症，达珠单抗HYP优于干扰素β-1α, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34c7569889d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982922, encodeId=45f11982922e3, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=CMSC 2016：多发性硬化症患者是否需要补充维生素D？, objectType=article, longId=70709, objectId=babfe07093b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=babfe07093b, replyNumber=0, likeNumber=144, createdTime=2017-05-16, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=babfe07093b, moduleTitle=CMSC 2016：多发性硬化症患者是否需要补充维生素D？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=babfe07093b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982904, encodeId=c988198290439, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Lancet：口服高剂量甲基强的松龙治疗多发性硬化症不劣于静脉注射, objectType=article, longId=52714, objectId=6c3752e1477, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c3752e1477, replyNumber=0, likeNumber=63, createdTime=2016-02-21, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c3752e1477, moduleTitle=Lancet：口服高剂量甲基强的松龙治疗多发性硬化症不劣于静脉注射, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c3752e1477)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982911, encodeId=3e8219829117f, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurosurg & Psychiat：多饮咖啡降真的能降低女性患多发硬化症风险吗？, objectType=article, longId=64186, objectId=301b6418611, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=301b6418611, replyNumber=0, likeNumber=104, createdTime=2017-02-10, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=301b6418611, moduleTitle=Neurosurg & Psychiat：多饮咖啡降真的能降低女性患多发硬化症风险吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=301b6418611)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982907, encodeId=31de198290ec4, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：TBK1无效突变易引起额颞叶痴呆和肌萎缩性脊髓侧索硬化症, objectType=article, longId=59262, objectId=3b5759262e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b5759262e8, replyNumber=0, likeNumber=106, createdTime=2016-04-21, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b5759262e8, moduleTitle=Neurology：TBK1无效突变易引起额颞叶痴呆和肌萎缩性脊髓侧索硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b5759262e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982912, encodeId=b08c198291243, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=一种植物肽可用于多发性硬化症预防及治疗, objectType=article, longId=66068, objectId=ee7566068f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee7566068f8, replyNumber=0, likeNumber=81, createdTime=2016-08-10, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee7566068f8, moduleTitle=一种植物肽可用于多发性硬化症预防及治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee7566068f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982902, encodeId=2b5f198290276, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Lancet：胃造瘘术对肌萎缩侧索硬化症的安全性和临床疗效, objectType=article, longId=51433, objectId=59755143397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59755143397, replyNumber=0, likeNumber=84, createdTime=2016-04-01, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59755143397, moduleTitle=Lancet：胃造瘘术对肌萎缩侧索硬化症的安全性和临床疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59755143397)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982897, encodeId=0392198289e91, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Lancet Neurol：环境危险因素与多发性硬化症, objectType=article, longId=47348, objectId=bd7f4e34868, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd7f4e34868, replyNumber=0, likeNumber=88, createdTime=2015-10-09, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd7f4e34868, moduleTitle=Lancet Neurol：环境危险因素与多发性硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd7f4e34868)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

硬化症

2020-05-29

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Clin Nutr：益生菌对多发性硬化症患者的好处实在是太多了！

2016-10-09

30397604 (审核中...)

前往app查看评论内容

#硬化症#

诺华新一代免疫调节剂BAF312（siponimod）治疗继发进展型多发性硬化症（SPMS）III期临床获得成功

2017-04-08

30397604 (审核中...)

前往app查看评论内容

#硬化症#

喜讯！FDA批准百健/艾伯维每月一次皮下注射多发性硬化症药物Zinbryta

2017-03-29

30397604 (审核中...)

前往app查看评论内容

#硬化症#

【盘点】多发性硬化症（MS）2016年研究新进展

2017-01-09

30397604 (审核中...)

前往app查看评论内容

#硬化症#

干细胞疗法真的可以治疗多发性硬化症吗？

2016-11-23

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Int J Epidemiol：肌萎缩侧索硬化症全球发病率研究（荟萃分析）

2016-08-12

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neuron：在多发性硬化症家系发现核受体基因NR1H3突变

2016-11-08

30397604 (审核中...)

前往app查看评论内容

#硬化症#

AAA 2015：喜大普奔！非处方药或可逆转多发性硬化症所致的视力损伤

2016-05-17

30397604 (审核中...)

前往app查看评论内容

#硬化症#

1年注射2次！罗氏多发性硬化症新药Ocrevus将2017年上市，年销轻松突破20亿美元

2016-09-20

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：大剂量补充维生素D可治疗多发性硬化症

2016-03-20

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：摄入维生素D或可帮助改善多发性硬化症患者的病情

2016-11-21

30397604 (审核中...)

前往app查看评论内容

#硬化症#

喜讯！百健和艾伯维每月一次皮下注射多发性硬化症药物Zinbryta获欧盟批准

2017-05-09

30397604 (审核中...)

前往app查看评论内容

#硬化症#

NEJM：治疗复发性多发性硬化症，达珠单抗HYP优于干扰素β-1α

2016-09-03

30397604 (审核中...)

前往app查看评论内容

#硬化症#

CMSC 2016：多发性硬化症患者是否需要补充维生素D？

2017-05-16

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Lancet：口服高剂量甲基强的松龙治疗多发性硬化症不劣于静脉注射

2016-02-21

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurosurg & Psychiat：多饮咖啡降真的能降低女性患多发硬化症风险吗？

2017-02-10

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：TBK1无效突变易引起额颞叶痴呆和肌萎缩性脊髓侧索硬化症

2016-04-21

30397604 (审核中...)

前往app查看评论内容

#硬化症#

一种植物肽可用于多发性硬化症预防及治疗

2016-08-10

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Lancet：胃造瘘术对肌萎缩侧索硬化症的安全性和临床疗效

2016-04-01

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Lancet Neurol：环境危险因素与多发性硬化症

2015-10-09

科室
- - 订阅+
  - 更多科室
工具
服务